A spin-and-climb board game where you're the sponsor and the contagion is your own clinical program. Draw a card, spin the wheel, and shepherd a real FDA-regulated product up the snake from first-in-human to a $9B exit — before the money, the clock, or the competition buries it. Can you run your trials fast enough?
Every game deals you an actual trial from ClinicalTrials.gov. A drug routes you through IND → phases → NDA/BLA. A device forks to 510(k) or PMA. The board knows the difference.
Each turn: draw a card from one of four decks (R&D, Enroll, FDA, Funding), then spin to climb the snake. Every square burns capital you'll miss later. Land on the right squares; dodge the gauntlet.
At the top of the board, make your case to Dr. Eleanor Vance of the Division of Regulatory Reckoning. She has read everything. She is not impressed. Her highest praise is "this is adequate." Convince her anyway.
The web rebirth of The Strategy Game (for Regulatory Affairs), a finished board game by Angela N. Johnson, PhD — SVP of Regulatory Affairs, 25+ years across FDA and EMA, the person who has actually received these letters so you can simply pretend to. A TRCL 501(c)(3) project, with support from Biotech Mentor LLC. Built on the same ClinicalTrials.gov pipeline as the trialcat map. For delight, not regulatory advice.
For the leaderboard. No password, no verification, no spam — your email is just a handle so we can tell two Angies apart. We never show it publicly (you'll appear as "First L."). This is a board game, not a clinical registry; we collect accordingly.
Six archetypes from the original board. Each one bends the climb. Pick the one whose delusion matches yours.